When Success Hides the Symptoms: Looking Past Productivity in High-Functioning Anxiety
Updated: 9 hours ago

Some clients arrive with a full calendar, strong performance reviews, and a private conviction that one mistake will expose them. Many now describe this experience as high-functioning anxiety. The phrase names anxiety that outward competence partly hides, and it has spread widely through news and social media. It is not a formal diagnosis, and no good research tracks how common it is (Stone, 2026).

This post examines what the label describes and where its scientific support ends. It then reviews assessment, lifestyle change, and three training-based adjuncts that our readers use every day. Each section separates what trials have shown from what remains uncertain. The goal is care that lowers the private cost of performing well, because protecting productivity alone is not enough.
A popular label with a thin research base
The term usually describes people who meet visible responsibilities while privately experiencing persistent worry, self-doubt, tension, or fear of failure. Brad Schmidt, who directs the Anxiety and Behavioral Health Clinic at Florida State University, lists typical outward signs. They include overpreparing, agreeing to every request, working late, and responding instantly. Privately, people may report poor sleep, muscle tension, irritability, and difficulty relaxing (Stone, 2026). The label's clinical value may be that it helps clients disclose distress others have overlooked.
The research base is small. Mellifont (2019) compared eight news texts with 36 journal articles on anxiety and work performance. The review found some support for reported strengths, such as work quality and output, and for difficulties such as perfectionism and overthinking. It was a thematic analysis, not a diagnostic validation study.
Pandya (2023) later compared online meditation lessons with online support-group sessions for professional Indian immigrants described as having high-functioning anxiety. Its abstract describes an evaluation of interventions, not a test of whether the construct is a distinct syndrome. Published research that explicitly uses the label remains limited. The studies reviewed here do not establish it as a distinct diagnostic construct. Public use of the term has outpaced research.
A sound diagnostic construct must clear several hurdles. Descriptive validity means the label captures an experience that clients and clinicians recognize. Reliability means different clinicians identify the same cases using consistent criteria. Discriminant validity means the construct differs meaningfully from generalized anxiety disorder (GAD), social anxiety, perfectionism, and ordinary stress. Incremental validity means the label improves prediction or treatment beyond established diagnoses and dimensional measures.
High-functioning anxiety may offer a recognizable and clinically useful description of distress behind outward competence. Its reliability, distinctness from established conditions, and added value for prediction or treatment have not been established. Absence from the diagnostic manual does not by itself invalidate a construct, and psychiatric diagnoses do not require a biomarker. Clinicians should not assume that people who identify with the term have mild symptoms or that deterioration is inevitable.
High-functioning anxiety is a useful description and an unvalidated category. It tells the clinician where to look, but not what is there. The label earns its place when it opens a conversation that a productivity record would otherwise close.
Preserved productivity does not rule out an anxiety diagnosis
The most important diagnostic point concerns GAD. The DSM-5-TR requires clinically significant distress or impairment, so occupational failure is not required (American Psychiatric Association [APA], 2022). An adult can remain highly productive and still meet criteria. The criteria require excessive, hard-to-control worry about several domains on most days for at least 6 months. They also require at least three associated symptoms, such as restlessness, fatigue, muscle tension, or disturbed sleep.
Clients who use this label therefore form a mixed group. Some have a full anxiety disorder, and others have subthreshold symptoms, adjustment-related anxiety, or understandable responses to excessive demands. Subthreshold presentations deserve attention in their own right. A systematic review of 18 epidemiological studies with 48,214 participants examined subthreshold GAD (Haller et al., 2014). It was about twice as common as the full syndrome, tended to persist, and impaired psychosocial and work functioning.
Other diagnoses can produce the same polished surface. Fear of negative evaluation suggests social anxiety disorder, and recurrent unexpected panic with later concern suggests panic disorder. Intrusive obsessions with compulsions may indicate obsessive-compulsive disorder, although perfectionism alone does not establish it. Depression, trauma-related symptoms, insomnia, and adjustment disorder also warrant consideration. A precise formulation would name persistent anxiety with preserved occupational performance and substantial distress, then add an established diagnosis when warranted.
The diagnostic manual asks whether worry causes significant distress or impairment. It does not ask whether the client still meets deadlines. A person can pay for excellent performance with sleep, health, and relationships, and that payment is clinical information.
Assess what the performance costs
Assessment should cover worry content, controllability, avoidance, checking, reassurance seeking, sleep, physical symptoms, substance use, relationships, and prior treatment. Guidance from the National Institute for Health and Care Excellence (NICE, 2020) adds comorbidity, medical conditions, and treatment history.
Ask how much time and effort ordinary tasks require. Two questions often reveal costs that a productivity measure misses. What happens if you stop preparing, and what do you give up to keep performing this way?
Behavioral symptoms deserve the same attention as worry. Beesdo-Baum et al. (2012) compared 56 patients with GAD and 33 healthy participants. Patients reported more cognitive avoidance, safety behavior, and reassurance seeking. These behaviors declined during behavior therapy, and greater avoidance after treatment predicted poorer long-term outcome. Counting these behaviors may therefore show progress that a symptom score misses.
Review medications, caffeine, alcohol, other substances, and withdrawal. Evaluate medical contributors when the history or examination suggests them. Apparent achievement should never replace assessment of suicide risk when it is clinically indicated.
No physiological test identifies this presentation. An international consensus statement found no candidate biomarker, including EEG and heart rate variability (HRV) measures, sufficient for diagnosing anxiety disorders (Bandelow et al., 2017).
A meta-analysis of 36 studies found lower resting HRV in anxiety disorders than in healthy controls (Chalmers et al., 2014). The differences were small to moderate, so the groups overlap extensively and the measure cannot classify an individual. Neither a quantitative EEG (qEEG) map nor an HRV threshold diagnoses high-functioning anxiety.
The GAD-7 is useful for screening and for monitoring generalized anxiety symptoms (Spitzer et al., 2006). It does not establish every diagnostic criterion, and it was not designed to measure high-functioning anxiety. Supplement scores with outcomes the client values. Examples include time lost to checking, sleep continuity, willingness to delegate, and participation in relationships.
A productivity record measures output. Assessment must also measure the price: hours of preparation, nights of broken sleep, and relationships placed on hold. Those costs, and the behaviors that sustain them, are treatment targets.
When hard work becomes a safety behavior
A safety behavior is an action taken to prevent a feared outcome or to reduce anxiety in the moment. Productivity can serve this function. A client predicts that an ordinary mistake will expose incompetence, checks the work repeatedly, and feels brief relief. That relief may reinforce checking while the feared prediction stays untested. Schmidt makes a similar point: such strategies lower anxiety briefly and strengthen the belief that success requires never letting up (Stone, 2026).
Worry itself may work the same way. The contrast avoidance model proposes that people with GAD use worry to stay braced for bad news (Newman & Llera, 2011). Sustained negative emotion feels safer than a sudden drop from calm to distress. Constant readiness can look like conscientiousness from the outside. These are hypotheses to explore with each client, not assumptions about everyone who works hard.
Perfectionism research separates two dimensions. Perfectionistic strivings are high personal standards, and perfectionistic concerns involve fear of mistakes and harsh self-evaluation.
Callaghan et al. (2024) pooled 416 studies with 113,118 adult participants. Perfectionistic concerns showed medium correlations with anxiety, obsessive-compulsive, and depressive symptoms, from .38 to .43. Strivings showed small correlations, from .10 to .21, and no association with social anxiety.
These correlations do not prove causation, but they clarify a practical distinction between preferring excellent work and being unable to stop checking it. Treatment trials are encouraging.
Galloway et al. (2022) pooled 15 randomized trials of cognitive behavioral therapy (CBT) for perfectionism with 912 participants. Perfectionism decreased, and anxiety symptoms showed a small-to-moderate improvement (Hedges' g = 0.42). Few trials used active comparisons, and participants averaged 23 years of age.
Overpreparing, checking, and constant availability can function as safety behaviors. They provide short-term relief and leave the feared prediction untested. The clinical task is to help the client discover what happens when they withhold the extra effort in a low-risk situation.
Lifestyle changes and structured behavioral interventions
Lifestyle interventions should be feasible, match the assessment, and reduce burden. Some clients need changes to workload, caregiving support, or organizational conditions as well as individual skills. For perfectionistic clients, a health behavior can become another rigid performance requirement. The plan should therefore stay small and flexible.
Exercise has credible evidence. Yao et al. (2026) pooled 34 randomized trials with 1,618 adults who had diagnosed anxiety disorders or elevated symptoms. Stand-alone exercise produced a moderate reduction in symptom severity across 26 trials, with a standardized mean difference (SMD) of −0.63 and moderate-certainty evidence.
A study-level dose-response analysis linked roughly 90 to 95 minutes of moderate weekly activity with moderate anxiety reduction; this is an estimate, not a prescription. The benefit of adding exercise to standard treatment was less certain because results varied widely across studies.
Protect adequate sleep opportunity and regular sleep-wake timing where feasible. For chronic insomnia, use or refer for multicomponent cognitive behavioral therapy for insomnia (CBT-I). The American Academy of Sleep Medicine strongly recommends CBT-I and advises against sleep hygiene as a stand-alone treatment (Edinger et al., 2021). In a meta-analysis of 21 trials in workers, CBT-I produced a large reduction in insomnia severity and a smaller reduction in anxiety (g = −0.35; Takano et al., 2023). This result supports treating insomnia, and it does not show remission of an underlying anxiety disorder.
Assess caffeine dose, timing, and sources, including energy drinks and pre-workout products. Challenge studies show that caffeine provokes panic attacks in about half of patients with panic disorder (Klevebrant & Frick, 2022). Those studies used roughly 400 to 750 mg, about five cups of coffee, so the finding should not be applied to every serving.
In a crossover trial, 150 mg did not significantly increase subjective anxiety in 29 patients with panic disorder or 53 healthy controls (Hoppe et al., 2025). It did increase skin conductance responses and avoidance behavior, so a gradual reduction with symptom tracking is a reasonable individual trial.
Ask whether alcohol is used to unwind or to fall asleep, and consider withdrawal when anxiety follows drinking. Support tobacco cessation while anticipating temporary withdrawal symptoms. A Cochrane review associated quitting with lower anxiety than continued smoking, although the certainty of that evidence was low (Taylor et al., 2021).
Cannabinoids should not be presented as established anxiety treatments. Wilson et al. (2026) reviewed 54 trials across several mental and substance use disorders. Four trials with 293 participants measured anxiety symptoms and showed no significant benefit, with very-low-certainty evidence. Across the disorders studied, cannabinoids raised the odds of adverse events.
Encourage adequate, regular meals and evaluate restrictive eating when indicated, but no dietary pattern is an established anxiety treatment. A review of 25 trials found that evidence for anxiety was limited by study quality and heterogeneity (Abukmail et al., 2025). | Recovery may also require limits on availability, more delegation, and protected leisure. If rest evokes guilt, a behavioral experiment might involve a brief break without compensatory checking. In safety-critical occupations, such experiments should use low-risk situations and preserve professional standards.
Structured mindfulness programs have meaningful evidence. Hoge et al. (2023) randomized 276 adults with anxiety disorders to eight weeks of mindfulness-based stress reduction (MBSR) or escitalopram. MBSR met the prespecified criterion for noninferiority. The program required weekly 2.5-hour classes, a daylong retreat, and 45 minutes of daily practice. These results support that intensive program and cannot establish equal efficacy for a brief meditation app.
Lifestyle change works best as a short list of feasible adjustments, not a second job. Exercise has supportive evidence for anxiety symptoms, CBT-I is an established treatment for chronic insomnia, and structured MBSR has trial evidence in anxiety disorders. For a perfectionistic client, the way a habit is practiced matters as much as the habit itself.
Biofeedback fits a documented problem
Biofeedback presents a physiological signal in real time so the client can practice changing a relevant response. Peripheral modalities include muscle activity, skin temperature, electrodermal activity, respiration, and cardiac timing. HRV biofeedback is one peripheral modality, whereas neurofeedback uses a measure of brain activity, most commonly EEG. These methods target different mechanisms and draw on different evidence bases.
Each modality suits a specific target. Surface electromyography (sEMG) can make sustained shoulder or forehead tension visible, although less muscle activity does not necessarily mean less worry. Thermal feedback teaches hand warming during relaxation, and temperature also reflects room conditions and vascular factors. Electrodermal feedback shows changes in sympathetic sweat-gland activity, which index arousal and are not specific to anxiety. Respiratory feedback and capnometry can identify breathing patterns, and findings in panic should not be generalized to all anxiety.
The evidence supports cautious use. Tolin et al. (2020) reviewed biofeedback and neurofeedback for anxiety disorders. Biofeedback outperformed waiting-list control conditions, but it was not superior to active treatments or to training in the countertherapeutic direction. Most studies were rated methodologically weak. For anxiety disorders, peripheral biofeedback is therefore a potentially useful, symptom-focused adjunct whose specific advantage over active treatments remains uncertain.
Capnometry illustrates the difference between benefit and mechanism. Kim et al. (2012) randomized 74 patients with panic disorder to raise end-tidal CO2, lower it, or wait. Both breathing trainings reduced panic severity, and gains held at six months. The authors attributed improvement to shared elements, such as changed expectancies, exposure to bodily sensations, and regular slow breathing. This finding does not justify lowering CO2 clinically.
Biofeedback makes one physiological response visible so that a client can practice changing it. In anxiety-disorder trials, biofeedback has outperformed waiting lists, and a specific advantage over active treatments has not been established. It works best with a defined target, such as sustained muscle tension, within a broader treatment plan.
HRV biofeedback: encouraging evidence with real limits
HRV is the variation in the time between successive heartbeats. HRV biofeedback displays cardiac timing, often alongside respiration, while the client practices slow, comfortable breathing. Normal breathing modulates heart rate in a pattern called respiratory sinus arrhythmia (RSA). Near a person's resonance frequency, respiration and the baroreflex interact to amplify heart rate oscillations (Lehrer & Gevirtz, 2014). Adult assessment commonly samples rates from 4.5 to 6.5 breaths per minute (Shaffer & Meehan, 2020).
The immediate oscillatory effect is well established, and the mechanisms behind lasting symptom change are less certain. Goessl et al. (2017) pooled 24 studies with 484 participants who received HRV biofeedback. The between-group effect on self-reported stress and anxiety was large (g = 0.83). The authors called for better-controlled studies, so this estimate is not expected to apply to an individual client. Lehrer et al. (2020) then reviewed 58 studies and found larger effects against inactive than active controls.
Newer findings are less uniform. A meta-analysis of 18 remote or hybrid studies with 1,352 participants found improved depressive symptoms and HRV (Vann-Adibe et al., 2026). Pooled effects on stress and anxiety were not significant. Only three studies measured anxiety, and two were nonrandomized with a high risk of bias. Training at resonance and practicing less than 20 minutes daily were associated with larger HRV gains, which does not establish an optimal dose or greater anxiety relief.
Two controlled trials show why physiological and clinical outcomes must be judged separately. Saito et al. (2024) randomized 55 anxious students and analyzed 40 after ten sessions. Resting HRV rose relative to an active control, and anxiety scores did not differ between groups. Sumińska et al. (2026) assigned 88 adults to individualized resonance training, fixed breathing at six breaths per minute, or a control group. Both training groups improved on symptoms, neither changed resting HRV, and individualized training showed no clear advantage.
Slow breathing alone changes cardiac oscillations, so a waiting-list comparison cannot isolate the feedback display's contribution. Laborde et al. (2022) tested slow-paced breathing with and without HRV biofeedback in 112 participants. Both conditions raised RMSSD and perceived control, with no interaction between condition and time. Feedback may still help some clients learn and sustain the skill. Its added clinical benefit over well-taught slow breathing remains uncertain, and short studies cannot rule out longer-term advantages.
Begin with symptom and functional goals, then teach easy breathing before pursuing large oscillations. A pragmatic starting dose is 5 to 10 minutes daily, progressing toward 10 to 20 minutes as tolerated. No optimal dose exists for this presentation. Lalanza et al. (2023) reviewed 143 studies and found that almost two-thirds omitted details needed for replication. Published protocols therefore offer limited dosing guidance.
Slow breathing should be gentle, because large breaths can lower CO2 even at a slow rate. Modify practice if dizziness, tingling, air hunger, or rising panic occurs. Do not slow breathing that compensates for metabolic acidosis, and interpret HRV cautiously when arrhythmias or pacing are present (Shaffer & Meehan, 2020). Teach transfer away from the screen. Requiring a favorable coherence score before daily activities could become another certainty-seeking behavior.
Keep training measurements separate from resting measurements. Recent guidelines stress that the input signal, recording length, setting, and analysis all affect HRV reliability (Carter et al., 2026). Those guidelines also state that HRV is not a specific marker of cardiac sympathetic outflow or sympathovagal balance. Greater low-frequency power during slow breathing therefore does not indicate greater sympathetic activity. The LF/HF ratio does not measure autonomic balance and should not be a treatment target (Billman, 2013).
HRV biofeedback is a reasonable adjunct for interested clients. Trials show that symptoms can improve without a change in resting HRV, and that resting HRV can rise without added symptom relief. The physiological score is a training aid, and the client's daily functioning is the outcome.
EEG neurofeedback remains preliminary and protocol-dependent
EEG neurofeedback records scalp electrical activity and provides feedback contingent on selected signal features. Through practice, the client learns to change that feedback, and conventional neurofeedback delivers no stimulating current to the brain. Studied approaches for anxiety include alpha, alpha-theta training, sensorimotor rhythm, and infraslow protocols. Findings for one protocol cannot establish the efficacy of another.
Russo et al. (2022) analyzed 12 single-group and 14 between-group studies of anxiety-spectrum conditions. Self-reported symptoms fell by nearly one standard deviation in both designs. The samples included people with posttraumatic stress symptoms. Such a pooled estimate does not by itself show that genuine feedback outperforms credible sham feedback. A consensus checklist now asks neurofeedback trials to report control conditions, blinding, and whether participants actually regulated the trained signal (Ros et al., 2020).
Two recent trials illustrate both promise and uncertainty. Dinc et al. (2025) compared nine sessions of alpha-theta training with prerecorded feedback in a single-blind design. Among 25 completers, GAD-7 scores fell from 13.67 to 8.00 with genuine feedback and barely changed with simulated feedback. The theta/alpha ratio rose within sessions but not across sessions. The small sample, single blinding, and self-report outcome limit confidence.
Perez et al. (2025) randomized 60 women with anxiety or depressive disorders to two infraslow protocols or sham. After six sessions, symptoms improved to a clinically important degree in every group. Changes did not differ between genuine and sham feedback, pointing to strong nonspecific effects. Connectivity in the targeted infraslow band also did not differ from sham. This result limits claims for that protocol and course, and it does not show that every protocol is ineffective.
No validated EEG signature identifies high-functioning anxiety, and a deviation from a normative database cannot determine a diagnosis or a protocol. If you offer neurofeedback, explain the uncertainty, specify the target and rationale, and define a reassessment point. Monitor for adverse effects. In a sham-controlled study of 30 healthy students, most participants reported transient side effects during training (Rogel et al., 2015). Time, cost, and displacement of established treatment should also be discussed in the consent process.
Neurofeedback for anxiety has a promising small trial and a careful sham-controlled trial that found no specific effect. A change in the trained signal does not prove clinical benefit. Symptom improvement does not prove that the intended neural mechanism caused it.
Integrating care
For diagnosed GAD, established treatment should remain readily available. Papola et al. (2024) analyzed 65 randomized trials with 5,048 adults. CBT reduced symptoms compared with usual care (SMD = −0.74) and was the only psychotherapy that showed a significant advantage over usual care at 3 to 12 months. NICE (2020) recommends CBT or applied relaxation as high-intensity psychological options and a selective serotonin reuptake inhibitor when medication is chosen. Adjunctive methods should build on this foundation and not delay it.
A practical plan follows five steps. First, establish the formulation and diagnosis, including medical and substance contributors. Second, agree on outcomes the client values, such as less checking, better sleep, or more social participation. Third, select a few feasible lifestyle changes and arrange disorder-appropriate treatment. Fourth, add biofeedback when its target fits the presentation, and fifth, review symptoms, functioning, adverse effects, and burden independently of physiological scores.
This sequence is an implementation framework, not a validated protocol for a new disorder. Its order reflects the strength of the evidence reviewed above. Established psychological treatment and well-supported lifestyle changes come first, followed by training-based adjuncts.
Start with the formulation, protect access to established treatment, and add adjuncts where they fit a defined target. Judge every component by the client's distress and daily life. Physiological scores inform training and do not define recovery.
Integrative summary and five key takeaways
High-functioning anxiety helps clients name distress that outward competence has concealed. The label has descriptive value and no demonstrated validity as a distinct disorder, so clinicians should assess established diagnoses and maintaining processes. Exercise, insomnia treatment, substance review, and changes to fear-driven habits can address symptoms and burdens. Biofeedback and HRV biofeedback can support selected self-regulation goals, and neurofeedback has a less established, protocol-dependent evidence base. Successful treatment improves well-being, flexibility, and sustainable functioning, and continued productivity alone is an inadequate measure of recovery.
1. High-functioning anxiety is a recognizable description, not a validated diagnosis. Use it to open assessment, then identify established disorders, subthreshold symptoms, or situational stress.
2. Preserved productivity does not exclude generalized anxiety disorder, because the criteria require significant distress or impairment, not occupational failure.
3. Assess the cost of functioning. Overpreparing, checking, and reassurance seeking may act as safety behaviors that maintain anxiety.
4. Exercise has supportive evidence for anxiety symptoms, and CBT-I is an established treatment for chronic insomnia. Caffeine, alcohol, nicotine, and cannabis deserve individual review, not blanket rules.
5. Biofeedback and neurofeedback are adjuncts. Judge them by symptoms and daily functioning, because physiological scores and clinical outcomes can move independently.
Glossary
alpha-theta training: a neurofeedback protocol that rewards changes in the relationship between alpha and theta activity, usually during eyes-closed relaxation.
baroreflex: the feedback system that adjusts heart rate and vessel tone to stabilize blood pressure.
biofeedback: training that displays a physiological signal in real time so a person can learn to change it.
capnometry: measurement of carbon dioxide in exhaled air, used to monitor breathing chemistry.
cognitive behavioral therapy (CBT): a structured psychotherapy that changes unhelpful thoughts and behaviors through skills practice, behavioral experiments, and exposure.
cognitive behavioral therapy for insomnia (CBT-I): a multicomponent insomnia treatment that typically combines sleep restriction, stimulus control, and cognitive strategies.
contrast avoidance: a model proposing that people with generalized anxiety disorder worry to avoid sudden shifts from a calm state to a distressed one.
discriminant validity: evidence that a construct differs meaningfully from related constructs.
DSM-5-TR: the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision, published by the American Psychiatric Association in 2022.
electrodermal activity: changes in the skin's electrical properties produced by sympathetic sweat-gland activity.
end-tidal CO2: the carbon dioxide concentration at the end of an exhaled breath, which estimates arterial carbon dioxide.
GAD-7: a seven-item self-report questionnaire used to screen for and monitor generalized anxiety symptoms.
generalized anxiety disorder (GAD): a disorder marked by excessive, hard-to-control worry on most days for at least six months, with associated symptoms and significant distress or impairment.
heart rate variability (HRV): variation in the time intervals between successive heartbeats.
Hedges' g: a standardized effect size that expresses a group difference in standard deviation units, corrected for small samples.
high-functioning anxiety: an informal term for persistent anxiety that is partly hidden by outward competence. It is not a formal diagnosis.
HRV biofeedback: training that displays cardiac timing while a person practices slow breathing to increase heart rate oscillations.
incremental validity: evidence that a construct improves prediction or treatment beyond existing diagnoses and measures.
infraslow: describing very slow EEG fluctuations, at or below 0.1 Hz.
LF/HF ratio: the ratio of low-frequency to high-frequency HRV power, once interpreted as autonomic balance and now considered invalid for that purpose.
low-frequency power: HRV power between 0.04 and 0.15 Hz, which slow breathing near 0.1 Hz increases through respiratory and baroreflex mechanisms.
mindfulness-based stress reduction (MBSR): an eight-week group program that teaches mindfulness meditation through weekly classes, a retreat, and daily home practice.
neurofeedback: biofeedback that uses a measure of brain activity, most often EEG, as the training signal.
noninferiority: a trial result showing that a treatment is not worse than a comparison treatment by more than a preset margin.
perfectionistic concerns: the dimension of perfectionism that involves fear of mistakes, doubt about actions, and harsh self-evaluation.
perfectionistic strivings: the dimension of perfectionism that involves setting high personal standards.
quantitative EEG (qEEG): numerical analysis of EEG, often compared with a normative database.
reassurance seeking: repeatedly asking others for confirmation that a feared outcome will not occur.
resonance frequency: the breathing rate, near six breaths per minute in most adults, that produces the largest heart rate oscillations.
respiratory sinus arrhythmia (RSA): the rise in heart rate during inhalation and the fall during exhalation.
RMSSD: the square root of the mean squared differences between successive normal-to-normal interbeat intervals. It measures short-term HRV and is influenced by cardiac vagal modulation and breathing.
safety behavior: an action taken to prevent a feared outcome or reduce anxiety, which can keep the fear from being tested.
sham feedback: a control condition in which the feedback signal is not tied to the participant's own physiological activity.
standardized mean difference (SMD): an effect size that expresses a group difference in standard deviation units so that different scales can be combined.
subthreshold: describing symptoms that cause distress or impairment but do not meet full diagnostic criteria.
surface electromyography (sEMG): measurement of muscle electrical activity with sensors placed on the skin.
waiting-list control: a comparison group that receives no treatment during the study and is offered it afterward.
References
Abukmail, E., Pradeep, N. K., Ahmed, S., & Albarqouni, L. (2025). Moderate- to long-term effect of dietary interventions for depression and anxiety: A systematic review and meta-analysis. Annals of Internal Medicine, 178(7), 987–999. https://doi.org/10.7326/ANNALS-24-03016
American Psychiatric Association. (2022). Diagnostic and statistical manual of mental disorders (5th ed., text rev.). https://doi.org/10.1176/appi.books.9780890425787
Bandelow, B., Baldwin, D., Abelli, M., Bolea-Alamanac, B., Bourin, M., Chamberlain, S. R., Cinosi, E., Davies, S., Domschke, K., Fineberg, N., Grünblatt, E., Jarema, M., Kim, Y.-K., Maron, E., Masdrakis, V., Mikova, O., Nutt, D., Pallanti, S., Pini, S., . . . Riederer, P. (2017). Biological markers for anxiety disorders, OCD and PTSD: A consensus statement. Part II: Neurochemistry, neurophysiology and neurocognition. The World Journal of Biological Psychiatry, 18(3), 162–214. https://doi.org/10.1080/15622975.2016.1190867
Beesdo-Baum, K., Jenjahn, E., Höfler, M., Lueken, U., Becker, E. S., & Hoyer, J. (2012). Avoidance, safety behavior, and reassurance seeking in generalized anxiety disorder. Depression and Anxiety, 29(11), 948–957. https://doi.org/10.1002/da.21955
Billman, G. E. (2013). The LF/HF ratio does not accurately measure cardiac sympatho-vagal balance. Frontiers in Physiology, 4, Article 26. https://doi.org/10.3389/fphys.2013.00026
Callaghan, T., Greene, D., Shafran, R., Lunn, J., & Egan, S. J. (2024). The relationships between perfectionism and symptoms of depression, anxiety and obsessive-compulsive disorder in adults: A systematic review and meta-analysis. Cognitive Behaviour Therapy, 53(2), 121–132. https://doi.org/10.1080/16506073.2023.2277121
Carter, J. R., Jenkins, N. D. M., Bigalke, J. A., Robinson, A. T., Keller-Ross, M. L., Greaney, J. L., Fonkoue, I. T., Fadel, P. J., Macefield, V. G., Charkoudian, N., Levine, B. D., & Joyner, M. J. (2026). Guidelines for rigor and reproducibility of heart rate variability within human cardiovascular research. American Journal of Physiology-Heart and Circulatory Physiology, 331(3), H918–H943. https://doi.org/10.1152/ajpheart.00041.2026
Chalmers, J. A., Quintana, D. S., Abbott, M. J.-A., & Kemp, A. H. (2014). Anxiety disorders are associated with reduced heart rate variability: A meta-analysis. Frontiers in Psychiatry, 5, Article 80. https://doi.org/10.3389/fpsyt.2014.00080
Dinc, L., Rybski, D., & Dineen, J. (2025). The effects of alpha/theta neurofeedback on mood, anxiety, emotion regulation and trait impulsivity. Brain Research, 1866, Article 149943. https://doi.org/10.1016/j.brainres.2025.149943
Edinger, J. D., Arnedt, J. T., Bertisch, S. M., Carney, C. E., Harrington, J. J., Lichstein, K. L., Sateia, M. J., Troxel, W. M., Zhou, E. S., Kazmi, U., Heald, J. L., & Martin, J. L. (2021). Behavioral and psychological treatments for chronic insomnia disorder in adults: An American Academy of Sleep Medicine clinical practice guideline. Journal of Clinical Sleep Medicine, 17(2), 255–262. https://doi.org/10.5664/jcsm.8986
Galloway, R., Watson, H., Greene, D., Shafran, R., & Egan, S. J. (2022). The efficacy of randomised controlled trials of cognitive behaviour therapy for perfectionism: A systematic review and meta-analysis. Cognitive Behaviour Therapy, 51(2), 170–184. https://doi.org/10.1080/16506073.2021.1952302
Goessl, V. C., Curtiss, J. E., & Hofmann, S. G. (2017). The effect of heart rate variability biofeedback training on stress and anxiety: A meta-analysis. Psychological Medicine, 47(15), 2578–2586. https://doi.org/10.1017/S0033291717001003
Haller, H., Cramer, H., Lauche, R., Gass, F., & Dobos, G. J. (2014). The prevalence and burden of subthreshold generalized anxiety disorder: A systematic review. BMC Psychiatry, 14, Article 128. https://doi.org/10.1186/1471-244X-14-128
Hoge, E. A., Bui, E., Mete, M., Dutton, M. A., Baker, A. W., & Simon, N. M. (2023). Mindfulness-based stress reduction vs escitalopram for the treatment of adults with anxiety disorders: A randomized clinical trial. JAMA Psychiatry, 80(1), 13–21. https://doi.org/10.1001/jamapsychiatry.2022.3679
Hoppe, J. M., Björkstrand, J., Vegelius, J., Klevebrant, L., Gingnell, M., & Frick, A. (2025). Acute effects of 150 mg caffeine on subjective, physiological, and behavioral components of anxiety in panic disorder and healthy controls: A randomized placebo-controlled crossover trial. Journal of Psychopharmacology, 39(8), 836–846. https://doi.org/10.1177/02698811251344692
Kim, S., Wollburg, E., & Roth, W. T. (2012). Opposing breathing therapies for panic disorder: A randomized controlled trial of lowering vs raising end-tidal P(CO2). The Journal of Clinical Psychiatry, 73(7), 931–939. https://doi.org/10.4088/JCP.11m07068
Klevebrant, L., & Frick, A. (2022). Effects of caffeine on anxiety and panic attacks in patients with panic disorder: A systematic review and meta-analysis. General Hospital Psychiatry, 74, 22–31. https://doi.org/10.1016/j.genhosppsych.2021.11.005
Laborde, S., Allen, M. S., Borges, U., Iskra, M., Zammit, N., You, M., Hosang, T., Mosley, E., & Dosseville, F. (2022). Psychophysiological effects of slow-paced breathing at six cycles per minute with or without heart rate variability biofeedback. Psychophysiology, 59(1), Article e13952. https://doi.org/10.1111/psyp.13952
Lalanza, J. F., Lorente, S., Bullich, R., García, C., Losilla, J.-M., & Capdevila, L. (2023). Methods for heart rate variability biofeedback (HRVB): A systematic review and guidelines. Applied Psychophysiology and Biofeedback, 48(3), 275–297. https://doi.org/10.1007/s10484-023-09582-6
Lehrer, P., Kaur, K., Sharma, A., Shah, K., Huseby, R., Bhavsar, J., Sgobba, P., & Zhang, Y. (2020). Heart rate variability biofeedback improves emotional and physical health and performance: A systematic review and meta analysis. Applied Psychophysiology and Biofeedback, 45(3), 109–129. https://doi.org/10.1007/s10484-020-09466-z
Lehrer, P. M., & Gevirtz, R. (2014). Heart rate variability biofeedback: How and why does it work? Frontiers in Psychology, 5, Article 756. https://doi.org/10.3389/fpsyg.2014.00756
Mellifont, D. (2019). Neuro magnifico! An exploratory study critically reviewing news text reporting of anxiety-related work performance strengths, challenges and support measures. Work, 63(3), 435–446. https://doi.org/10.3233/WOR-192950
National Institute for Health and Care Excellence. (2020). Generalised anxiety disorder and panic disorder in adults: Management (NICE Clinical Guideline CG113). https://www.nice.org.uk/guidance/cg113
Newman, M. G., & Llera, S. J. (2011). A novel theory of experiential avoidance in generalized anxiety disorder: A review and synthesis of research supporting a contrast avoidance model of worry. Clinical Psychology Review, 31(3), 371–382. https://doi.org/10.1016/j.cpr.2011.01.008
Pandya, S. P. (2023). Professional immigrants and high-functioning anxiety: Assessing some interventions. Human Resource Development International, 26(5), 521–547. https://doi.org/10.1080/13678868.2023.2170200
Papola, D., Miguel, C., Mazzaglia, M., Franco, P., Tedeschi, F., Romero, S. A., Patel, A. R., Ostuzzi, G., Gastaldon, C., Karyotaki, E., Harrer, M., Purgato, M., Sijbrandij, M., Patel, V., Furukawa, T. A., Cuijpers, P., & Barbui, C. (2024). Psychotherapies for generalized anxiety disorder in adults: A systematic review and network meta-analysis of randomized clinical trials. JAMA Psychiatry, 81(3), 250–259. https://doi.org/10.1001/jamapsychiatry.2023.3971
Perez, T. M., Adhia, D. B., Glue, P., Zeng, J., Dillingham, P., Navid, M. S., Niazi, I. K., Young, C. K., Smith, M., & De Ridder, D. (2025). Infraslow closed-loop brain training for anxiety and depression (ISAD): A pilot randomised, sham-controlled trial in adult females with internalizing disorders. Cognitive, Affective, & Behavioral Neuroscience, 25(4), 1147–1180. https://doi.org/10.3758/s13415-025-01279-z
Rogel, A., Guez, J., Getter, N., Keha, E., Cohen, T., Amor, T., & Todder, D. (2015). Transient adverse side effects during neurofeedback training: A randomized, sham-controlled, double blind study. Applied Psychophysiology and Biofeedback, 40(3), 209–218. https://doi.org/10.1007/s10484-015-9289-6
Ros, T., Enriquez-Geppert, S., Zotev, V., Young, K. D., Wood, G., Whitfield-Gabrieli, S., Wan, F., Vuilleumier, P., Vialatte, F., Van De Ville, D., Todder, D., Surmeli, T., Sulzer, J. S., Strehl, U., Sterman, M. B., Steiner, N. J., Sorger, B., Soekadar, S. R., Sitaram, R., . . . Thibault, R. T. (2020). Consensus on the reporting and experimental design of clinical and cognitive-behavioural neurofeedback studies (CRED-nf checklist). Brain, 143(6), 1674–1685. https://doi.org/10.1093/brain/awaa009
Russo, G. M., Balkin, R. S., & Lenz, A. S. (2022). A meta-analysis of neurofeedback for treating anxiety-spectrum disorders. Journal of Counseling & Development, 100(3), 236–251. https://doi.org/10.1002/jcad.12424
Saito, R., Yoshida, K., Sawamura, D., Watanabe, A., Tokikuni, Y., & Sakai, S. (2024). Effects of heart rate variability biofeedback training on anxiety reduction and brain activity: A randomized active-controlled study using EEG. Applied Psychophysiology and Biofeedback, 49(4), 603–617. https://doi.org/10.1007/s10484-024-09650-5
Shaffer, F., & Meehan, Z. M. (2020). A practical guide to resonance frequency assessment for heart rate variability biofeedback. Frontiers in Neuroscience, 14, Article 570400. https://doi.org/10.3389/fnins.2020.570400
Spitzer, R. L., Kroenke, K., Williams, J. B. W., & Löwe, B. (2006). A brief measure for assessing generalized anxiety disorder: The GAD-7. Archives of Internal Medicine, 166(10), 1092–1097. https://doi.org/10.1001/archinte.166.10.1092
Stone, S. (2026, May 18). FSU expert available to discuss high-functioning anxiety during Mental Health Awareness Month. Florida State University News. https://news.fsu.edu/news/expert-pitches/2026/05/18/fsu-expert-available-to-discuss-high-functioning-anxiety-during-mental-health-awareness-month/
Sumińska, S., Rynkiewicz, A., & Szulczewski, M. T. (2026). Resonance frequency versus fixed 0.1 Hz breathing in HRV biofeedback: A four-week randomized comparison. Scientific Reports, 16, Article 22630. https://doi.org/10.1038/s41598-026-53333-6
Takano, Y., Ibata, R., Machida, N., Ubara, A., & Okajima, I. (2023). Effect of cognitive behavioral therapy for insomnia in workers: A systematic review and meta-analysis of randomized controlled trials. Sleep Medicine Reviews, 71, Article 101839. https://doi.org/10.1016/j.smrv.2023.101839
Taylor, G. M. J., Lindson, N., Farley, A., Leinberger-Jabari, A., Sawyer, K., te Water Naudé, R., Theodoulou, A., King, N., Burke, C., & Aveyard, P. (2021). Smoking cessation for improving mental health. Cochrane Database of Systematic Reviews, 2021(3), Article CD013522. https://doi.org/10.1002/14651858.CD013522.pub2
Tolin, D. F., Davies, C. D., Moskow, D. M., & Hofmann, S. G. (2020). Biofeedback and neurofeedback for anxiety disorders: A quantitative and qualitative systematic review. In Y.-K. Kim (Ed.), Anxiety disorders: Rethinking and understanding recent discoveries (pp. 265–289). Springer. https://doi.org/10.1007/978-981-32-9705-0_16
Vann-Adibe, S., Tsui, H. K. H., Zhou, H. Q., Ciren, Z., Li, C., & Cha, S. K. W. (2026). Efficacy and methodology of remote heart rate variability biofeedback interventions for mental health: A systematic review and meta-analysis. Applied Psychophysiology and Biofeedback, 51(3), 441–452. https://doi.org/10.1007/s10484-025-09750-w
Wilson, J., Dobson, O., Langcake, A., Mishra, P., Bryant, Z., Leung, J., Dawson, D., Graham, M., Teesson, M., Freeman, T. P., Hall, W., Chan, G. C. K., & Stockings, E. (2026). The efficacy and safety of cannabinoids for the treatment of mental disorders and substance use disorders: A systematic review and meta-analysis. The Lancet Psychiatry, 13(4), 304–315. https://doi.org/10.1016/S2215-0366(26)00015-5
Yao, Y., Li, N., Shi, J., Wang, W., Huang, H., Liu, S., & Li, Y. (2026). Effects of exercise as a stand-alone intervention or adjunct to standard treatment on anxiety outcomes in adults: A systematic review and meta-analysis. Journal of Anxiety Disorders, 125, Article 103258. https://doi.org/10.1016/j.janxdis.2026.103258




Comments